Home » Topics » BioWorld Science

BioWorld Science
RSS

Connetics amends payment terms, sells Canadian rights to Ridaura

Jan. 22, 1998

Commencement of Ossigel clinical trials

Jan. 22, 1998

Gastrimmune significantly increases survival in advanced colorectal cancer

Jan. 22, 1998

Genetronics to begin phase II head and neck cancer trial in Canada

Jan. 22, 1998

HMR and Abbott sign marketing agreement for Anzemet

Jan. 22, 1998

Botox compared to saline for chronic anal fissure

Jan. 22, 1998

Dexketoprofen trometamol approved in E.U. countries

Jan. 22, 1998

T Cell Sciences and Walter Reed collaborate on inhibition of liposome-induced complement activation

Jan. 22, 1998

Korean researchers characterize new antimicrobial/cytotoxic compound of microbial origin

Jan. 22, 1998

Repligen and Glaxo extend Glyceptor collaboration

Jan. 22, 1998

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...